NEW ARTICLE: MEBENDAZOLE and Thyroid Cancer – Inhibits Tumor Growth and Prevents Lung Metastasis – Shocking New Johns Hopkins Research on...
Vous n'êtes pas connecté
A new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma, was approved Aug. 6 by the U.S. Food and Drug Administration (FDA). The promising new drug stems from a 2008 genetic discovery made at the Johns Hopkins Kimmel Cancer Center, USA. The drug, called vorasidenib, is a targeted cancer therapy that works [...]
NEW ARTICLE: MEBENDAZOLE and Thyroid Cancer – Inhibits Tumor Growth and Prevents Lung Metastasis – Shocking New Johns Hopkins Research on...
Using a new workflow that integrates spatial transcriptomics and machine learning for imaging analysis and integration with single-cell datasets,...
Health experts said the medicine could give children more time without their brain tumour growing and improve quality of life.
Health experts said the medicine could give children more time without their brain tumour growing and improve quality of life.
Illumina's cancer biomarker test, TSO Comprehensive, gets approved by the FDA for use as CDx to match patients with targeted therapies.
Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers
Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers
The 3D Urology and Prostate Clinics introduce their groundbreaking 3D Prostate Cancer Targeted Treatment, offering innovative and effective solutions...
Researchers at the National Institute of Biology are exploring new avenues for more effective treatment of glioblastoma, the most aggressive form of...
Researchers from the University of Missouri have found that an FDA-approved drug used to lower blood sugar in adults with type 2 diabetes may also...